ClinConnect ClinConnect Logo
Search / Trial NCT05719220

Effect of Group Preoperative Pelvic Floor Training for HoLEP

Launched by UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · Jan 31, 2023

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

Benign Prostatic Hyperplasia Pelvic Floor Training Group Therapy Holmium Laser Enucleation Of The Prostate Urinary Incontinence

ClinConnect Summary

This clinical trial is studying whether group pelvic floor training before surgery can help prevent urinary incontinence in men who are undergoing a specific type of prostate surgery called Holmium laser enucleation of the prostate (HoLEP). Urinary incontinence is when someone has trouble controlling their urine, which can be a concern after this kind of surgery. The researchers hope that by participating in this training, patients may have better outcomes and reduce the risk of incontinence after their procedure.

To be eligible for this trial, participants must be male, aged between 50 and 90, and diagnosed with benign prostatic hyperplasia (BPH), which is an enlargement of the prostate. They should be able to understand the study and give their consent to participate. However, individuals who have severe urinary incontinence due to past neurological issues, or who cannot follow the training protocol, will not be included. If you join the study, you can expect to participate in group training sessions focused on strengthening pelvic floor muscles, along with regular follow-ups to track your progress and any changes in symptoms. This research could lead to better ways to manage urinary incontinence for future patients undergoing HoLEP surgery.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Consecutive patients with a diagnosis of BPH with a plan to undergo HoLEP.
  • Between the age of 50-90.
  • Ability to understand and provide informed consent.
  • Exclusion Criteria:
  • Patients whom inability to carry out PFT protocol.
  • Patients unwilling or unable to complete follow up care.
  • Severe urinary incontinence due to a history of neurological diseases such as a cerebrovascular accident or spinal cord injuries.
  • Patients whom inability to read and understand the English language.

About University Of California, San Francisco

The University of California, San Francisco (UCSF) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on translating scientific discoveries into effective therapies, UCSF collaborates with a diverse array of stakeholders, including healthcare professionals, industry partners, and patient communities. The university's research programs emphasize interdisciplinary approaches and leverage cutting-edge technology to address complex medical challenges. As a sponsor of clinical trials, UCSF is dedicated to maintaining the highest standards of ethical conduct and scientific rigor, ensuring the safety and well-being of participants while contributing to the broader medical knowledge base.

Locations

San Francisco, California, United States

Patients applied

0 patients applied

Trial Officials

Thomas Chi, M.D.

Principal Investigator

University of California, San Francisco

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials